Kadcyla 100mg Injection

Kadcyla 100mg Injection works by combining the targeting ability of trastuzumab, which binds to HER2-positive cancer cells, with the cell-killing effects of emtansine, a chemotherapy drug. Once this medication binds to the HER2-positive cancer cells, it releases emtansine, which then enters the cancer cells and destroys them. This process helps to slow down or stop the growth of cancer, reducing the size of tumors and potentially extending the patient’s life.

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Kadcyla 100mg Injection and cause undesirable side effects.

• Kadcyla 100mg Injection should be stored in refrigerator at 2°C to 8°C (36°F to 46°F).
• Protected from light.
• Keep it in its original packaging until it is ready to be used.
• Keep reaching out of the reach of children and pets.
• It should be disposed of properly.

Kadcyla 100mg Injection is administered by a healthcare professional in a hospital or clinic setting. The dose and frequency depend on several factors, such as the individual’s age, weight, overall health, and the type and stage of the cancer being treated.

Kadcyla 100mg Injection can cause side effects like all medications, although not everyone who takes it will experience them.

Serious:

• Infusion reactions, including fever, chills, rash, or difficulty breathing
• Lung problems, including shortness of breath, cough, or fever
• Heart problems, including heart failure or abnormal heart rhythms
• Severe bleeding or bruising
• Nerve damage, including numbness, tingling, or weakness
• Severe allergic reactions

Common:

• Fatigue
• Nausea
• Constipation
• Muscle or joint pain
• Headache
• Fever
• Low platelet count
• High liver enzyme levels
• Low red blood cell count
• Loss of appetite
• Rash or itching